Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
3,605,567
-
Shares change
-
+109,727
-
Total reported value, excl. options
-
$446,754,001
-
Value change
-
+$14,480,513
-
Put/Call ratio
-
107%
-
Number of buys
-
62
-
Number of sells
-
42
-
Price
-
$123.93
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2017
As of 30 Sep 2017 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,605,567 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, ROYAL BANK OF CANADA, LPL Financial LLC, RAYMOND JAMES & ASSOCIATES, AMERIPRISE FINANCIAL INC, J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD, and Hartford Financial Management Inc..
This table shows 141 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.